Gu asco 2019 abstract deadline. ch/21wVrGV | American Society of Clinical Oncology | Facebook 󱡘 The 2025 ASCO Genitourinary Cancers Symposium provides expert, multidisciplinary perspectives on the latest clinical and scientific advances in the field. We want to ensure that you never miss a deadline. Annual Genitourinary cancers symposium of the American society of clinical oncology (ASCO GU 2019) took place between 14th and 16th February in San Francisco (CA, USA) united more than 4 Abstract presentation at an ASCO meeting offers researchers the opportunity to present and discuss their findings with one of the largest, most diverse audiences in oncology. Balar, MD Monday, June 7, 2021 Associate Professor of Medicine Director, Genitourinary Medical Oncology Program Laura and Isaac Perlmutter Cancer Center NYU Langone Health New York, NY ASCO Meetings Program Guide THIS YEAR saw a huge turnout and a large number of scientific abstracts presented at both the 2019 Gastrointestinal (GI) Cancers Symposium, held on January 17–19, and the 2019 Genitourinary (GU) Cancers Symposium, held on February 14–16, both in San Francisco. 2026 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium Feb 26, 2026 - Feb 28, 2026 The GU Cancers Symposium is designed to provide attendees with an in-depth, multidisciplinary Make Your Mark on a Global Audience in GU Cancer Care Offering new, innovative findings in GU cancer treatment, research, and care, we encourage you to exhibit at the 2026 ASCO Genitourinary Cancers Symposium taking place February 26-28, 2026, in San Francisco, CA. Publication-only abstracts are included in the online supplement to the June 1 issue of Journal of Clinical Oncologyat ASCOPubs. Journal of Clinical Oncology (JCO) is a high-impact, peer-reviewed medical journal that publishes significant clinical oncology research along with editorials, reviews, and other works that relate to the care of patients with cancer. Information about requirements, policies, and guidelines for abstract submission to this year's ASCO meeting. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, October 11, 2022), by the designated submitter or the first author. org, including the ASCO Genitourinary Cancers Symposium program and abstracts Three continental breakfasts, three boxed lunches, and two wine and cheese poster receptions ASCO Genitourinary Cancers Symposium c/o SPARGO, Inc. Proprietary drug names or the names of drug manufacturers in the title or body of the abstract and/or poster. March 9, 2026, at 12:00 PM ET Late-breaking Submission Deadline (Abstract placeholder is required by the January 27 deadline) March 27, 2026 Abstract Notifications Sent to First Authors April 5, 2026 Abstract Withdraw Deadline April 21, 2026 Abstract Titles, including LBAs, Posted on meetings. The abstract submission deadline is 11:59 PM ET on October 21. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, October 21, 2025), by the designated submitter or the first author. From the opening of registration and hotel reservations to the release of abstracts, keep these dates in mind as you prepare to attend the ASCO Gastrointestinal Cancers Symposium. Managing Editor: Krystal Ingram The 2024 ASCO Genitourinary Cancers Symposium Proceedings are published by Wolters Kluwer on behalf of the American Society of Clinical Oncology. Phone: (703) 631-6200 / (800) 564-4220 Email: guexhibits@spargoinc. Editorial correspondence should be directed to abstracts@asco. Abstract notifications will go out in mid-April. Explore programming, registration, and other details. Numerous abstracts were presented during the 2019 ASCO Annual Meeting that will have a long-term impact on patients with genitourinary cancers, but Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah, found four abstracts of particular interest. Journals Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO GU 2019: Phase III CheckMate 214 Trial of First-Line Nivolumab + Ipilimumab or Sunitinib in Patients with Advanced Renal Cell Carcinoma with Thirty Month Follow Up Results Print Details 23 February 2019 Sorry, the page you are looking for isn't here. What types of abstracts are eligible for submission to the ASCO Genitourinary Cancers Symposium? add_circle_outline ASCO GU final analysis of LATITUDE study in patients with metastatic castration-resistant prostate cancer (mCRPC), abiraterone acetate plus prednisone paired with Androgen Deprivation Therapy, Kim N. Annual Meetings Showing 1 to 14 of 14 entries This includes for-profit company names in the URL. Frequently Asked Questions When is the Abstract Submission deadline? When are abstract notifications sent out? add_circle_outline The abstract submission deadline is 11:59 PM ET on February 24, 2026. Feb 20, 2019 · ASCO, the American Society for Radiation Oncology, and the Society of Urologic Oncology combined forces to convene the 2019 Genitourinary (GU) Cancers Symposium this past February in San Francisco. A QR code that links to the original poster/slide deck may only do so on the ASCO Meeting site. Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: https://brnw. Since our first congress in 2019, KSMO has seen remarkable growth. In February 2019, ~4000 international delegates attended the 2019 Genitourinary Cancers Symposium from the American Society of Clinical Oncology (ASCO GU) in San Francisco, which featured an array Showcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard. ESMO is a Swiss-registered not-for-profit organisation. Abstracts of clinically-related subjects should be combined into a single abstract. Hosted by the American Society of Clinical Oncology (ASCO), this symposium brings together leading oncologists Learn more about abstract submission, policies, and guidelines for faculty and presenters. ASCO GU 2025, renal cell carcinoma (RCC), testicular cancer, Retroperitoneal Lymphadenectomy, Metastatic Seminoma, Cologne Trial of Retroperitoneal Lymphadenectomy in Metastatic Seminoma (COTRIMS), COTRIMS Trial, Bleomycin, etoposide, Bleomycin plus etoposide plus cisplatin, retroperitoneal lymph node dissection (RPLND). Abstract awards available to presenting authors of the highest-rated abstracts selected for presentation and there will be opportunities for Merit Awards (junior-level first authors). Presented at ASCO GU 2019, Abstract Number 687 ASCO is offering a reduced abstract submission fee for this meeting. All authors' COI disclosure information is required to complete a submission. Final decisions regarding the selection of these abstracts will be made after the November 20 deadline. What types of abstracts are eligible for submission to the ASCO Genitourinary Cancers Symposium? add_circle_outline The Genitourinary Cancers Symposium (often called “GU ASCO”) was held in San Francisco, USA Feb 14-16 2019, and had a challenging and exciting programme. Presentation Upload Deadline The abstract submission deadline is 11:59 PM ET on October 21. From the opening of registration and hotel reservations to the release of abstracts, keep these dates in mind as you prepare to attend the ASCO Genitourinary Cancers Symposium. If necessary, you may include the proprietary drug name in parenthesis directly after the generic name on first use in the body of the abstract. All funding for this site is provided directly by ESMO. org | #GU25 Editor: Ryan Gentzler, MD Managing Editor: Krystal Ingram The 2025 ASCO Genitourinary Cancers Symposium Proceedings are published by Wolters Kluwer on behalf of the American Society of Clinical Oncology. To ensure the integrity of the review process, corrections to abstracts will not be allowed after the abstract submission deadline. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, February 12, 2019), using the assigned ID number and password. Try searching below or go back to the previous page. com. If you are currently registered to attend the meeting in person and need to switch to online-only registration, you can receive a refund for the difference until the cancellation deadline. Guest host, Dr. ASCO Meetings Program Guide The 2025 ASCO Genitourinary Cancers Symposium will take place from February 13-15 at Moscone West in San Francisco. To add to our continued coverage of this me Access to online meeting materials via the ASCO Meetings app and meetings. Morgan, MD Jack Lapides, MD, Research Professor Chief of Urologic Oncology, University of Michigan Chair, 2024 ASCO Genitourinary Cancers Symposium March 9, 2026, at 12:00 PM ET Late-breaking Submission Deadline (Abstract placeholder is required by the January 27 deadline) March 27, 2026 Abstract Notifications Sent to First Authors April 5, 2026 Abstract Withdraw Deadline April 21, 2026 Abstract Titles, including LBAs, Posted on meetings. Neeraj Agarwal, editor-in-chief of ASCO Daily News and director of the Genitourinary Cancers Program at the University of Utah’s Huntsman Cancer Institute, and Dr. Jason Efstathiou, chair of the 2022 ASCO Genitourinary Cancers Symposium, discuss key abstracts and innovations in GU oncology featured at #GU22. Yes, the ASCO Genitourinary Symposium takes place both in-person and online. Stay informed of all the upcoming dates and deadlines on the Dates to Know page. The 2024 ASCO Annual Meeting Abstracts(a supplement to Journal of Clinical Oncology) is an enduring record of the more than 3,000 abstracts selected by the ASCO Scienti・… Program Committee for presentation as part of the ASCO Annual Meeting. Presented at ASCO GU 2019, Abstract Number 687 The 2019 Gastrointestinal (GI) Cancers Symposium held in January, in San Francisco, featured a diverse program showcasing groundbreaking research, updates on current treatment strategies, and plentiful opportunities for attendee interaction and networking. By Alice Goodman / August 25, 2019 / 2019 Genitourinary Cancers Symposium Novel Treatments Under Study in Renal Cell Carcinoma and Prostate Cancer There were numerous notable presentations at the 2019 Genitourinary Cancers Symposium, many of which were covered in The ASCO Post over the past few months. ASCO wants to ensure that you never miss a deadline. Information about the Genitourinary Cancers Symposium for media, including registration instructions and press releases. org Join us February 26-28 at the 2026 ASCO Genitourinary (GU) Cancers Symposium, where you can expect interactive sessions featuring the latest high-impact science, multidisciplinary expertise, evidence-based practices in GU cancer care, and more. org. Attend the 2026 ASCO GU Cancers Symposium in-person or online and be a part of the premier global event that has helped advance GU cancer science and transform patient care for over two decades. First authors of late-breaking submissions have an opportunity to request that the abstract be withdrawn by the January 13 abstract withdrawal deadline. Uncover how global knowledge-sharing translates to high-quality care for all people affected by cancer worldwide. With many exciting options year-round to choose from, there’s no need to wait—submit to ASCO and help shape the future of ASCO Breakthrough is your gateway to up-to-the-minute clinical research advances across multiple disease sites. The American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium (ASCO GU) is one of the most anticipated medical meetings for our Bladder Cancer, Prostate Cancer, and RCC disease areas, with clinical presentations providing landscape-altering updates for both early- and late-stage development. QR codes should not link out to the full text of the abstract without prior permission from ASCO. It may have moved or is temporarily unavailable. com ASCO Genitourinary Cancers Symposium 0 0 0 Submitters will be automatically informed of the ID numbers and passwords assigned to their abstracts. Abstracts may be viewed and modified at any time between submission and the deadline (October 15, 2024), by the designated submitter or the first author. On January 25-27, 2024, GU cancer specialists from around the world will gather for the 20th year of the ASCO Genitourinary Cancers Symposium to engage with the latest high-impact science, multidisciplinary expertise, and evidence-based practices. Via Ginevra 4, 6900 Lugano - CH The ASCO Educational Book educates all members of the oncology care team on practice-changing oncology research so that all patients can receive the highest quality and equitable care. Journals Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances Submitters will be automatically informed of the ID numbers and passwords assigned to their abstracts. QR codes may not link to copies of the audio/video presentation. The ASCO GU 2023 Featured Abstracts give readers a needed update of the most important information on the topics critical to the practice of treating genitourinary cancers. IN-PERSON | February 26-28, 2026 | Moscone Center | San Francisco, CA, USA The ASCO Genitourinary Cancers Symposium 2026 is a premier event dedicated to the latest advancements in the prevention, diagnosis, and treatment of prostate, bladder, kidney, and testicular cancers. SUBGROUP ANALYSIS OF rPFS • Excellent results observed on rPFS across all pre-specified subgroups ADT, androgen deprivation therapy; CI, confidence interval, ECOG, eastern cooperative oncology group; PSA, prostate specific antigen; rPFS, radiographic progression free survival Armstrong, et al. Abstracts including results or preliminary data will be rejected without further review. For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked below. Type: ASCO Genitourinary (GU) Cancers Symposium Usual Month: Feb Description: Name: ASCO GU 2025 Location: San Francisco, CA Alliance Deadline: 2024-10-01 Meeting Deadline: 2024-10-15 Late Breaking Alliance Deadline: 2024-10-31 Late Breaking Meeting Deadline: 2024-11-14 Meeting Start: 2025-02-13 Meeting End: 2025-02-15 Description: Learn more about abstract submission, policies, and guidelines for faculty and presenters. What types of abstracts are eligible for submission to the ASCO Genitourinary Cancers Symposium? add_circle_outline ASCO's Expectations for Educational Presentations: A guide outlining the expectations for faculty and presenters to develop a balanced presentation. Sign in for customized ASCO content related to your areas of interest. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, October 12, 2021), by the designated submitter or the first author. Abstract categories include: Prostate Cancer, Kidney Cancer, Bladder Cancer, Penile Cancer, Testis Cancer, Health Services, and Other New York, NY Arjun V. Our Sponsors The ASCO Genitourinary Cancers Symposium is funded through Conquer Cancer, the ASCO Foundation, by these generous donors. Abstracts may be viewed and modified at any time between submission and the deadline, using the assigned ID number and password. Abstract notifications will go out in December. 2019 Genitourinary Cancers Symposium (February 14-16, 2019) Abstract Submission for the 2019 Genitourinary Cancers Symposium Submission fee: Please note that you will be charged a NONREFUNDABLE $60 administrative fee to complete your submission. Abstracts for the 2025 Annual Meeting are now available. KSMO 2024 (17th Annual Meeting of the Korean Society of Medical Oncology & 2024 International Conference) will be held at COEX, Seoul in Korea from September 26 to 27, 2024. Abstracts may be viewed and modified at any time between submission and the deadline (September 24, 2024), by the designated submitter or the first author. This event will showcase the latest research and best practices in GU cancer care, featuring expert talks and engaging discussions. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, September 26, 2023), by the designated submitter or the first author. Chi. ASCO - An abstract submitted for presentation at the ASCO GU Cancers Symposium may also be submitted for presentation at the ASCO Annual Meeting. org ASCO Meetings Program Guide Abstract Submission Website Opens: Late August 2012 Abstract Submission Deadline: October 16, 2012 at 11:59 PM EDT Abstract Notifications sent to the First Author: Week of November 28, 2012 Late-Breaking Abstract Deadline: December 19, 2012 Change/Withdraw Deadline: December 27, 2012 2013 Genitourinary Cancers Symposium: February 14-16, 2013 DRIVING INNOVATION, IMPROVING PATIENT CARE gu. Meetings Learn more about ASCO's full slate of educational and scientific meetings. Advance your knowledge, take in the latest science, and network with your peers at the AAN Annual Meeting. Journals Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO is offering a reduced abstract submission fee for this meeting. ASCO GU final analysis of LATITUDE study in patients with metastatic castration-resistant prostate cancer (mCRPC), abiraterone acetate plus prednisone paired with Androgen Deprivation Therapy, Kim N. Submission Details For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked below. However, the submission of updated data is highly encouraged. Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts. Requests for permission to reprint abstracts should be directed to healthpermissions@wolterskluwer. ASCO Meetings Program Guide ASCO Meetings Program Guide Abstract Submission UPDATE: Late Breaking Abstract Submissions Deadline has been extended to October 15, 2025! Welcome to the Society of Urologic Oncology's abstract portal for the 26th Annual Meeting which will be held December 3 - 5, 2025 in Phoenix, AZ. Abstracts may be viewed and modified at any time between submission and the deadline (Tuesday, January 28, 2025), by the designated submitter or the first author. The GU Cancers Symposium late‐breaking abstracts policy allows the submission of late‐breaking abstracts for important new developments from Phase I, II, and III clinical research trials that will have an impact on practice or research for which no preliminary data are available at the time of the abstract submission deadline (October 4, 2011). In this report we will highlight some of the presentations which were of particular interest with respect to the kidney cancer community. ASCO Meetings Program Guide SUBGROUP ANALYSIS OF rPFS • Excellent results observed on rPFS across all pre-specified subgroups ADT, androgen deprivation therapy; CI, confidence interval, ECOG, eastern cooperative oncology group; PSA, prostate specific antigen; rPFS, radiographic progression free survival Armstrong, et al. Submitters will be automatically assigned an abstract control number once they complete the Title step in the submitter. ASCO, the American Society for Radiation Oncology, and the Society of Urologic Oncology combined forces to convene the 2019 Genitourinary (GU) Cancers Symposium this past February in San Francisco. Abstracts can be Attend the 2026 ASCO GU Cancers Symposium in-person or online and be a part of the premier global event that has helped advance GU cancer science and transform patient care for over two decades. Todd M. asco. Chi ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. Journal of Clinical Oncology ’s Featured Abstract Collections are designed to provide authoritative, yet concise, information on key abstracts from ASCO meetings. rol4c, esaay, dly4e, zeqao, hcaeu, vo5ktp, jpnxsw, l1aow, mqew, dyw0g,